固定与基于体重的原胺复合物缩剂剂量策略的比较,用于XA因子抑制剂逆转
Snyder Brett1, Miller Taylor1, McCormick Pamela1
1Department of Pharmacy, UPMC Mercy, Pittsburgh, PA, USA.
概括
定剂量前热复合物缩剂 (PCC) 是扭转XA因子抑制剂 (FXaI) 作用的可行选择,其血液静止率和死亡率与基于体重的剂量可比.
科学领域:
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
背景情况:
- 为了简化管理,实施了定剂量前素复合缩剂 (PCC).
- 之前的研究表明,固定剂量PCC对维生素K抗剂逆转的疗效.
- 这项研究评估了固定剂量的PCC对Xa因子抑制剂 (FXaI) 的逆转.
研究的目的:
- 为了比较固定剂量与基于体重的PCC用于FXaI逆转的疗效和安全性.
- 评估对给药时间,血液静止和患者结局的影响.
主要方法:
- 在高等学术医疗中心进行回顾性队列研究.
- 包括接受PCC治疗阿皮克萨班或里瓦罗克萨班逆转的患者.
- 固定剂量PCC (5000或2000单位) 与基于体重的PCC (50单位/公斤) 的比较.
主要成果:
- 固定剂量 (34.5分钟) 和基于体重 (39分钟) 的PCC之间,中位数的施用时间相似.
- 固定剂量治疗79.2%的患者实现了静血,而基于体重的PCC治疗71.3%的患者实现了静血.
- 没有观察到与出血相关的手术,死亡率或不良事件的显著差异.
结论:
- 固定剂量PCC用于FXaI逆转,显示血液静止和死亡率与基于体重的剂量相比较.
- 固定的剂量策略是一个可行的,可能更有效的选择.
- 进一步的研究可能会探索最佳的固定剂量策略.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
686
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
686
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Clot Retraction and Fibrinolysis
5.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.6K
Steady State Concentration
4.4K
A steady state refers to the level of a drug in the body once it has reached an equilibrium between administration and elimination. It represents the point at which the drug administration rate equals the drug elimination rate, resulting in a relatively constant concentration in the body over time. The dynamic equilibrium is crucial to ensure the drug's effectiveness with minimal risk of toxicity.
Most drugs are administered in repeated doses at fixed intervals or through continuous...
Most drugs are administered in repeated doses at fixed intervals or through continuous...
4.4K


